Sperti Drug Products, Inc., et al.; Withdrawal of Approval of 40 New Drug Applications

로컬 자동 번역 · 원본 출처 언어

요약

The Food and Drug Administration (FDA) is withdrawing 40 new drug applications (NDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports on these NDA's.

원본 출처 언어: Federal Register — All Documents원문 발표 열기 →